Total Returns (Price + Dividend) 
Sharma E I Hosp. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
How has been the historical performance of Sharma E I Hosp.?
Answer: The historical performance of Sharma E I Hosp. shows significant fluctuations in its financial metrics over the years. Breakdown: Sharma E I Hosp. has experienced notable changes in its net sales, which increased from 8.13 Cr in Mar'21 to 29.87 Cr in Mar'25, reflecting a strong upward trend. The total operating income followed a similar trajectory, rising from 8.13 Cr in Mar'21 to 29.87 Cr in Mar'25. However, the company faced challenges with total expenditure, which also increased from 8.78 Cr in Mar'21 to 26.22 Cr in Mar'25. This led to an operating profit (PBDIT) that fluctuated, reaching 3.65 Cr in Mar'25 after a loss of 1.88 Cr in Mar'24. The profit before tax improved from 0.84 Cr in Mar'21 to 1.41 Cr in Mar'25, while profit after tax also saw an increase, rising from 0.64 Cr in Mar'21 to 1.24 Cr in Mar'25. The company's total assets grew from 16.29 Cr in Mar'18 to 27.67 Cr in Mar'25, indicat...
Read MoreWhy is Sharma E I Hosp. falling/rising?
As of N/A, Sharma East India Hosp and Medical Research Ltd is experiencing a price increase, currently at 132.00, reflecting a rise of 6.0 or 4.76%. Unfortunately, today's price summary data is not available, which limits the ability to provide further insights into the stock's immediate trading activity. However, the stock has shown significant performance over the year, with a year-to-date increase of 46.05% and a remarkable 120.70% rise over the past year, indicating strong long-term growth despite recent short-term declines of 6.42% over the past week and 7.37% over the past month. In the broader market context, the Sensex has performed positively, gaining 1.21% over the past week and 2.38% over the past month, contrasting with Sharma East India Hosp's recent declines. Despite the stock's short-term underperformance relative to the benchmark, its substantial year-to-date and yearly gains suggest that i...
Read More Announcements 
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
14-Jan-2026 | Source : BSECompliance Certificate under regualtion 74(5) of SEBI (DP) Regulation 2018 for the quarter ended December 2025
Closure of Trading Window
30-Dec-2025 | Source : BSEIntimation For Closure Of Trading Window For Quarter ended 31st Dec 2025.
Intimation Of Reconstitution Of Audit Committee And Nomination And Remuneration Committee Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
14-Nov-2025 | Source : BSEAs per attachment
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
No Data Found
Valuation key factors
No Data Found
Technicals key factors
Shareholding Snapshot
Shareholding Compare (%holding) 
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -0.95% vs 58.36% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -13.51% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 19.82% vs 44.80% in Sep 2024
Growth in half year ended Sep 2025 is 8.47% vs 51.28% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 61.29% vs -10.66% in Mar 2024
YoY Growth in year ended Mar 2025 is 87.88% vs -20.48% in Mar 2024